Cargando…
Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy
Autoantibodies to the heat shock protein 90 (Hsp 90) have been reported as prognostic marker in breast cancer patients. Sera from 20 high-grade osteosarcoma patients were tested at the time of diagnosis by enzyme-linked immunosorbent assay. Presence of anti-Hsp90 antibodies correlated with a better...
Autores principales: | Trieb, K, Gerth, R, Holzer, G, Grohs, J G, Berger, P, Kotz, R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363193/ https://www.ncbi.nlm.nih.gov/pubmed/10638971 http://dx.doi.org/10.1054/bjoc.1999.0881 |
Ejemplares similares
-
Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis
por: Sitko, Krzysztof, et al.
Publicado: (2021) -
Antibodies to Heat Shock Proteins 90α and 90β in Psoriasis
por: Damasiewicz-Bodzek, Aleksandra, et al.
Publicado: (2020) -
Recurrence rate and progression of chondrosarcoma is correlated with heat shock protein expression
por: TRIEB, KLEMENS, et al.
Publicado: (2016) -
Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
por: Park, Sangkyu, et al.
Publicado: (2019) -
Inhibitory effects of heat shock protein 90 blockade on proinflammatory human Th1 and Th17 cell subpopulations
por: Tukaj, Stefan, et al.
Publicado: (2014)